97 results
Page 3 of 5
8-K
EX-10.1
16r7zhvj7u7eo9
5 May 22
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
bt342lor4 9yag
1 Mar 22
First Wave BioPharma, Inc. Announces $9 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
5:07pm
8-K
EX-10.1
ebehiybn38yimzmin rj
17 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:15am
8-K
EX-10.1
g77ncb6ur7b0p
7 Feb 22
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.1
6xjk zadrl3t4fu2b15z
16 Nov 21
First Wave Biopharma Announces Restructuring of Merger Consideration Payment Terms with Former Shareholders of First Wave Bio
5:04pm
8-K
EX-10
tof59g4p
10 Mar 21
AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:49am
8-K/A
EX-10.1
3t3cnjibwzxyr
13 Jan 21
Financial Statements and Exhibits
5:29pm
8-K
EX-10
o6pehdhebl69b9i
8 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10
whpl7g xiy
4 Jan 21
Agreement expands AzurRx’s pipeline of targeted, non-systemic GI therapies
7:32am
8-K
EX-10
f7sku6t0rfnr5e8983p8
4 Jan 21
Agreement expands AzurRx’s pipeline of targeted, non-systemic GI therapies
7:32am
8-K
EX-10
vdjm69va
20 Jul 20
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
9:03am
8-K
EX-10
c0ecvml
20 Jul 20
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
9:03am
8-K
EX-10
k5u20
20 Jul 20
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
9:03am
8-K
EX-10.1
33ch4xmq6g 7wvxboaq
6 Jan 20
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer
4:12pm
8-K
EX-10
ddtm7
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-10
dxwn6ckj cbwisp5
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-10
hmqota10n9yf538e
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-10
cjrge0be0zn2k
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-10.1
5wj7o
14 Nov 19
AzurRx BioPharma, Inc. Announces Equity Purchase Agreement
9:00am